Furfuryl methacrylate (FMA) is a colorless liquid monomer that finds applications in the synthesis of polymers and resins. It is typically synthesized through a reaction of methacryloyl chloride with furfuryl alcohol in the presence of a base. FMA is known for its ability to polymerize readily, forming cross-linked networks with excellent adhesion properties. These properties make it valuable for use in various applications, including adhesives, coatings, and composites. The presence of the furan ring in FMA contributes to its unique reactivity, allowing it to participate in various chemical modifications and reactions. FMA has been investigated for its potential in different fields, including biomedicine, where its biocompatibility and ability to form hydrogels with controlled properties have shown promise in tissue engineering and drug delivery. Further research on FMA focuses on exploring its use in renewable and sustainable materials, due to its potential as a bio-based monomer derived from plant-based resources.'
furfuryl methacrylate: a hydrophobic monomer; can be prepared from vegetable residues such as corn husks and sugar cane [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 76993 |
| SCHEMBL ID | 36525 |
| MeSH ID | M0227729 |
| Synonym |
|---|
| 2-propenoic acid, 2-methyl-, 2-furanylmethyl ester |
| einecs 222-383-5 |
| nsc 61377 |
| nsc 24164 |
| nsc24164 |
| 3454-28-2 |
| nsc-24164 |
| methacrylic acid, furfuryl ester |
| furfuryl methacrylate |
| nsc61377 |
| nsc-61377 |
| furfuryl methacrylate, 97%, contains 200 ppm monomethyl ether hydroquinone as inhibitor |
| methacrylic acid furfuryl ester |
| M1335 |
| furan-2-ylmethyl 2-methylprop-2-enoate |
| FT-0634863 |
| AKOS022182945 |
| SCHEMBL36525 |
| DTXSID9063037 |
| furfurylmethacrylate |
| mfcd00046113 |
| (furan-2-yl)methyl 2-methylprop-2-enoate |
| AS-59854 |
| furfuryl methacrylate (stabilized with mehq) |
| furfuryl methacrylate, (stabilized with mehq) |
| J-019643 |
| DWXAVNJYFLGAEF-UHFFFAOYSA-N |
| furan-2-ylmethyl methacrylate |
| H10790 |
| SB60973 |
| A874945 |
| 29320-19-2 |
| Q94ZA4KCV7 |
Furfuryl methacrylate (FMA) is a promising precursor for producing polymers for biomedical and cell therapy applications.
| Excerpt | Reference | Relevance |
|---|---|---|
| "Furfuryl methacrylate (FMA) is a promising precursor for producing polymers for biomedical and cell therapy applications. " | ( Furfuryl methacrylate plasma polymers for biomedical applications. Michelmore, A; Rogers, N; Shirazi, HS; Whittle, JD, 2016) | 3.32 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (26.40) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||